Fibroblast growth factor-2 mediates transforming growth factor-β action in prostate cancer reactive stroma (original) (raw)

• Akhurst RJ, Derynck R . (2001). TGF-beta signaling in cancer—a double-edged sword. Trends Cell Biol 11: S44–S51.
  CAS Google Scholar
• Backhaus R, Zehe C, Wegehingel S, Kehlenbach A, Schwappach B, Nickel W . (2004). Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J Cell Sci 117: 1727–1736.
  Article CAS Google Scholar
• Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S et al. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848–851.
  Article CAS Google Scholar
• Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M et al. (2004). Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 173: 2099–2108.
  Article CAS Google Scholar
• Butter S, Laping NJ, Pullen M, Grygielko E, Olson B, Brooks DP . (2001). The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production. Eur J Pharmacol 422: 47–52.
  Article CAS Google Scholar
• Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R et al. (2005). Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24: 5053–5068.
  Article CAS Google Scholar
• Choy L, Skillington J, Derynck R . (2000). Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 149: 667–682.
  Article CAS Google Scholar
• Coffey Jr RJ, Shipley GD, Moses HL . (1986). Production of transforming growth factors by human colon cancer lines. Cancer Res 46: 1164–1169.
  CAS Google Scholar
• Derynck R, Zhang YE . (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577–584.
  Article CAS Google Scholar
• Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G . (1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103–111.
  Article CAS Google Scholar
• Dow JK, deVere White RW . (2000). Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 55: 800–806.
  Article CAS Google Scholar
• Dvorak HF . (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 315: 1650–1659.
  Article CAS Google Scholar
• Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT et al. (1995). Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 73: 628–635.
  CAS Google Scholar
• Fukabori Y, Nakano K, Ohyama A, Yamanaka H . (1997). Stimulative effect of transforming growth factor-beta on collagen synthesis by human prostatic stromal cells in vitro. Int J Urol 4: 597–602.
  Article CAS Google Scholar
• Giri D, Ropiquet F, Ittmann M . (1999). Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5: 1063–1071.
  CAS Google Scholar
• Hayashi T, Hideshima T, Nguyen AN, Munoz O, Podar K, Hamasaki M et al. (2004). Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment. Clin Cancer Res 10: 7540–7546.
  Article CAS Google Scholar
• Huss WJ, Barrios RJ, Foster BA, Greenberg NM . (2003). Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression. Prostate 54: 8–16.
  Article Google Scholar
• Igarashi A, Okochi H, Bradham DM, Grotendorst GR . (1993). Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637–645.
  Article CAS Google Scholar
• Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K et al. (2004). Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 165: 203–217.
  Article CAS Google Scholar
• Liotta LA, Kohn EC . (2001). The microenvironment of the tumour–host interface. Nature 411: 375–379.
  Article CAS Google Scholar
• Peehl DM, Sellers RG . (1998). Basic FGF, EGF, and PDGF modify TGFbeta-induction of smooth muscle cell phenotype in human prostatic stromal cells. Prostate 35: 125–134.
  Article CAS Google Scholar
• Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O et al. (1994). Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269: 6271–6274.
  CAS Google Scholar
• Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S et al. (2003). Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res 63: 5754–5760.
  CAS Google Scholar
• Roberts AB, Russo A, Felici A, Flanders KC . (2003). Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann NY Acad Sci 995: 1–10.
  Article CAS Google Scholar
• Roberts AB, Sporn MB . (1996). Transforming growth factor-β. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair. Plenum Press: New York, NY, pp 275–308.
  Google Scholar
• Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM et al. (1986). Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171.
  Article CAS Google Scholar
• Ronnov-Jessen L, Petersen OW, Bissell MJ . (1996). Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76: 69–125.
  Article CAS Google Scholar
• Rowley DR . (2007). Reactive stroma and evolution of tumors: integration of transforming growth factor-beta, connective tissue growth factor, and fibroblast growth factor-2 activities. In: Jakowlew S (ed). Transforming Growth Factor-Beta in Cancer Therapy. Humana Press: Towta.
  Google Scholar
• Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, Horsfall DJ . (2001). Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res 61: 926–930.
  CAS Google Scholar
• Silver DP, Livingston DM . (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233–243.
  Article CAS Google Scholar
• Story MT, Hopp KA, Meier DA . (1996). Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate 28: 219–226.
  Article CAS Google Scholar
• Tuxhorn JA, Ayala GE, Rowley DR . (2001). Reactive stroma in prostate cancer progression. J Urol 166: 2472–2483.
  Article CAS Google Scholar
• Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR . (2002a). Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912–2923.
  CAS Google Scholar
• Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR . (2002b). Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62: 3298–3307.
  CAS Google Scholar
• Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR . (2002c). Inhibition of TGF-β activity decreases angiogenesis in a human prostate cancer reactive stroma xenograft model. Cancer Res 62: 6021–6025.
  CAS Google Scholar
• Uchiyama-Tanaka Y, Matsubara H, Mori Y, Kosaki A, Kishimoto N, Amano K et al. (2002). Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int 62: 799–808.
  Article CAS Google Scholar
• Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR . (2005). Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887–8895.
  Article CAS Google Scholar